conduct as with fraud. The gist of defendants’ argument is that “it is hard to comprehend how Schwab allegedly could have systematically misstated the maturity dates, prices, and descriptions of the securities in the fund, and exceeded a known concentration limit for over a year, without doing so intentionally” (Br. at 6).
This order is unable to hold that the conduct alleged necessarily sounds in fraud. Other explanations are certainly possible. Indeed, although the complaint does not specifically plead negligence (plaintiffs make that argument only in their opposition brief), it alleges a potentially non-fraudulent cause of the misrepresentations' — that the misstatements arose from breakdowns in internal controls (Compl.Ht 92, 94). Assuming that material misstatements occurred, is possible that many of the defendants were unaware of the fund’s increasing risk and deviations from stated investment policies, and/or were merely negligent in failing to recognize and prevent them.
The Ninth Circuit has applied Rule 9(b) to Section 11 claims where the plaintiff pled both fraud and non-fraud bases for liability based on the same course of conduct. In re Daou Systems, Inc., 411 F.3d at 1027. See also In re Stac Electronics Securities Litigation, 89 F.3d at 1404-05 & n. 2 (in that situation, “nominal” efforts to disclaim fraud were “unconvincing”). No published Ninth Circuit decision has been found, however, applying Rule 9(b)’s particularity requirement to a Section 11 claim where, as here, the underlying conduct was not also alleged to have constituted fraud. Courts generally apply Rule 8 to Section 11 claims where only non-fraud bases for liability are pled or where such claims are adequately distinguished from fraud claims. See, e.g., In re Suprema Specialties, Inc. Securities Litigation, 438 F.3d 256, 270-73 (3d Cir.2006); Romine v. Acxiom Corp., 296 F.3d 701 (8th Cir.2002); In re Exodus Communications, Inc. Securities Litigation, 2005 WL 2206693 (N.D.Cal.2005) (unpublished) (Chesney, J.). The Ninth Circuit has reached the same result in unpublished opinions. Safron Capital Corp. v. Leadis Technology, Inc., 274 Fed.Appx. 540 (9th Cir.2008); Knollenberg v. Harmonic, Inc., 152 Fed.Appx. 674 (9th Cir. 2005). This order declines to characterize the claims as necessarily sounding in fraud where plaintiffs have not expressly pled fraud and have pled non-fraud bases for liability. For these reasons, Rule 8 governs the claim; defendants motion to dismiss the Section 11 claim for failure to satisfy Rule 9(b) is denied.
(ii) Loss Causation.
As stated, loss causation is not an element of the prima facie case under Section 11, but defendants may assert a lack of loss causation as an affirmative defense. See 15 U.S.C. 77k(e). District courts have dismissed Section 11 claims on the pleadings where it was apparent on the face of the complaint that the plaintiffs would be unable to establish loss causation. See, e.g., In re DNAP Securities Litigation, 2000 WL 1358619, *3 (N.D.Cal.2000) (unpublished) (Alsup, J.); In re Countrywide Financial Corp. Securities Litigation, 588 F.Supp.2d 1132, 1169-70 (C.D.Cal.2008) (Pfaelzer, J.). Defendants contend that this is such a case.
Defendants reasoning is as follows. Plaintiffs are investors in a mutual fund rather than in an individual security. The price of shares in a mutual fund — the fund’s net asset value — -is determined entirely by the value of the assets in the fund’s portfolio: “the value of a mutual fund share is calculated according to a statutory formula. Share price is a function of ‘Net Asset Value,’ the pro-rata share of assets under management, minus liabilities such as fees.” In re Morgan Stanley and Van Kampen Mut. Fund Securities Litigation, 2006 WL 1008138, at *9 (S.D.N.Y.2006). Thus, even if the fund misrepresented its investment policies and/or risk profile, those misrepresentations could not have caused plaintiffs’ losses because the misrepresentations did not cause the decline in the value of the portfolio’s asset holdings.
Surface appeal aside, defendants restrict the concept of loss causation is too narrowly. Loss causation is “a causal connection between the material misrepresentation and the loss.” Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336, 342, 125 S.Ct.